Investors in Repligen Corporation RGEN need to pay close attention to the stock based on moves in the options market lately.

During the last three months, 5 analysts shared their evaluations of Repligen (NASDAQ:RGEN), revealing diverse outlooks from bullish to bearish. The following table encapsulates their recent ratings, ...

A month has gone by since the last earnings report for Repligen (RGEN). Shares have lost about 13.5% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up ...

Repligen (NasdaqGS:RGEN) reported earnings in which revenue exceeded company guidance. Operating income also came in ahead of ...

We recently published Top 10 Stock Recommendations You Can’t Miss Amid Growing AI Bubble Fears. Repligen Corporation (NASDAQ:RGEN) is one of the top recommended stocks. Dan Veru, Palisade Capital ...

Repligen Corp (NASDAQ:RGEN) released on Tuesday third-quarter adjusted EPS of 43 cents, up from 23 cents a year ago, beating the consensus of 33 cents. The bioprocessing technology reported sales of ...

Providing a diverse range of perspectives from bullish to bearish, 8 analysts have published ratings on Repligen (NASDAQ:RGEN) in the last three months. The following table encapsulates their recent ...

Repligen (RGEN) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives a ...

In the preceding three months, 5 analysts have released ratings for Repligen (NASDAQ:RGEN), presenting a wide array of perspectives from bullish to bearish. The table below summarizes their recent ...

We recently published a list of Top 10 Stocks to Buy According to 12 West Capital Management. In this article, we are going to take a look at where Repligen Corporation (NASDAQ:RGEN) stands against ...